3Kwong YL, Au WY, Chim CS, et al. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia, clinicopathological and molecular features of a pilot study. Am J Hematol, 2001, 66(4): 274-279. 被引量：1
4Sanz MA. All-trans retinoic acid anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood, 2004, 104 (12) : 3490-3493. 被引量：1
5Sanz MA, Martin G, Lo Coco F. Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia. Best Pract Res Clin Haematol, 2003, 16(3): 433-451. 被引量：1
6Gu BW, Hu J, Xu L, et al. Feasibility and clinical significance of real-time quantitative RT-PCR assay of PML-RARa pha fusion transcript in patients with acute promyelocytic leukemia. Hematol J, 2001, 2(5): 330-340. 被引量：1
8Schnittger S, Weisser M, Schoch C, et al, New score predicting for prognosis in PML-RARα -k, AML/ETO -k, CBF/MYH11 acute myeloid leukemia based on quantification of fusion transcripts. Blood, 2003, 102:2746-2755. 被引量：1
9Higuchi T, Kizaki M, Omine M. Induction of differentiation of retinoic acid-resistant acute promyelocytic leukemia cells by the combination of all-trans retinoic acid and granulocyte colony-stimulating factor. Leuk Res, 2004, 28(5): 525-532. 被引量：1
10Daruka M, Alan FL. Targeting the multidrug resistance-1 transporter inAML: molecular regulation and therapeutic strategies. Blood, 2004,104(7):1940-1951. 被引量：1
